Tags

Type your tag names separated by a space and hit enter

Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis: Cochrane systematic review

Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis: Cochrane systematic review is a topic covered in the Cochrane Abstracts.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

"Non-absorbable Disaccharides Versus Placebo/no Intervention and Lactulose Versus Lactitol for the Prevention and Treatment of Hepatic Encephalopathy in People With Cirrhosis: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432156/all/Non_absorbable_disaccharides_versus_placebo_no_intervention_and_lactulose_versus_lactitol_for_the_prevention_and_treatment_of_hepatic_encephalopathy_in_people_with_cirrhosis:_Cochrane_systematic_review. Accessed 21 July 2019.
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432156/all/Non_absorbable_disaccharides_versus_placebo_no_intervention_and_lactulose_versus_lactitol_for_the_prevention_and_treatment_of_hepatic_encephalopathy_in_people_with_cirrhosis:_Cochrane_systematic_review. Accessed July 21, 2019.
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis: Cochrane systematic review. In Cochrane Abstracts. Available from https://evidence.unboundmedicine.com/evidence/view/Cochrane/432156/all/Non_absorbable_disaccharides_versus_placebo_no_intervention_and_lactulose_versus_lactitol_for_the_prevention_and_treatment_of_hepatic_encephalopathy_in_people_with_cirrhosis:_Cochrane_systematic_review
Non-absorbable Disaccharides Versus Placebo/no Intervention and Lactulose Versus Lactitol for the Prevention and Treatment of Hepatic Encephalopathy in People With Cirrhosis: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2019 July 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432156/all/Non_absorbable_disaccharides_versus_placebo_no_intervention_and_lactulose_versus_lactitol_for_the_prevention_and_treatment_of_hepatic_encephalopathy_in_people_with_cirrhosis:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis: Cochrane systematic review ID - 432156 BT - Cochrane Abstracts UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432156/all/Non_absorbable_disaccharides_versus_placebo_no_intervention_and_lactulose_versus_lactitol_for_the_prevention_and_treatment_of_hepatic_encephalopathy_in_people_with_cirrhosis:_Cochrane_systematic_review DB - Evidence Central DP - Unbound Medicine ER -